Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
- Resource Type
- Article
- Authors
- Falchook, Gerald S; Lewis, Karl D; Infante, Jeffrey R; Gordon, Michael S; Vogelzang, Nicholas J; DeMarini, Douglas J; Sun, Peng; Moy, Christopher; Szabo, Stephen A; Roadcap, Lori T; Peddareddigari, Vijay GR; Lebowitz, Peter F; Le, Ngocdiep T; Burris, Howard A, III; Messersmith, Wells A; O'Dwyer, Peter J; Kim, Kevin B; Flaherty, Keith; Bendell, Johanna C; Gonzalez, Rene; Kurzrock, Razelle; Fecher, Leslie A
- Source
- In Lancet Oncology August 2012 13(8):782-789
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045